Skip to main content

UNC Institute to Use InforSense Software for PGx Programs

NEW YORK (GenomeWeb News) - The University of North Carolina at Chapel Hill has licensed InforSense's workflow-based analytics platform for use in pharmacogenomics research projects, the company said yesterday.
 
The Institute of Pharmacogenomics and Individualized Therapy at UNC-CH will use the GenSense software in its efforts to develop "precise, effective treatment options for individual patients suffering from a wide range of conditions," InforSense said.
 
The institute is focused on identifying genetic variants that may predispose patients to severe side effects or poor response to certain drugs.
 
The company said the GenSense software will enable IPIT to "leverage expression data, DNA and micoarray analysis, electronic medical records, and various relational databases to drive its interdisciplinary research initiatives."
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.